KANILAD 200mg tablets medication leaflet

N03AX18 lacosamide • Nervous system | Antiepileptics | Other antiepileptics

Lacosamide is an antiepileptic medication used for the treatment of partial-onset seizures, with or without secondary generalization. It works by stabilizing abnormal electrical activity in the brain.

The medication is administered orally or intravenously, as directed by a doctor. The dose is gradually adjusted to reduce the risk of side effects.

Side effects may include dizziness, nausea, fatigue, or balance disturbances. In rare cases, severe allergic reactions or cardiac arrhythmias may occur.

Lacosamide is not recommended for patients with hypersensitivity to this medication or certain cardiac conditions, such as second- or third-degree atrioventricular block.

General data about KANILAD 200mg

Substance: lacosamide

Date of last drug list: 01-05-2018

Commercial code: W64253004

Concentration: 200mg

Pharmaceutical form: tablets

Quantity: 56

Product type: generic

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: MEDOCHEMIE LTD. - CIPRU

Holder: MEDOCHEMIE LTD. - CIPRU

Number: 10483/2018/04

Shelf life: 3 years

Pharmaceutical forms available for lacosamide

Concentrations available for lacosamide

100mg, 10mg/ml, 150mg, 15mg/ml, 200mg, 50mg